JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

Home・Listă Acțiuni・Avita Therapeutics Inc

Avita Therapeutics Inc

Închisă

4.54 2.02

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

4.41

Maxim

4.67

Indicatori cheie
By Trading Economics
Venit	1.6M -12M
Vânzări	554K 18M
Marjă de profit	-65.968
Angajați	226
EBITDA	1.6M -9.7M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+41.93% upside

Dividende
By Dow Jones
Următoarele câștiguri	14 mai 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	30M 153M
Deschiderea anterioară	2.52
Închiderea anterioară	4.54

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

8.83 / 9.77 Suport & Rezistență

Avita Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

27 apr. 2026, 23:15 UTC

Evenimente importante

U.K. Consumers Pay Less But Full Impact of Mideast War to Be Seen

27 apr. 2026, 23:08 UTC

Câștiguri

Principalele dinamici ale pieței

LendingClub Shares Gain on 1Q Profit, Revenue Beat

27 apr. 2026, 23:58 UTC

Câștiguri

Samsung SDI 1Q Net Profit Beat FactSet-Compiled Consensus

27 apr. 2026, 23:58 UTC

Câștiguri

Samsung SDI 1Q Net KRW56.10B Vs. Loss KRW216.00B >006400.SE

27 apr. 2026, 23:56 UTC

Câștiguri

Samsung SDI 1Q Oper Loss KRW155.60B Vs. Loss KRW434.10B >006400.SE

27 apr. 2026, 23:56 UTC

Câștiguri

Samsung SDI 1Q Rev KRW3.576T Vs. KRW3.177T >006400.SE

27 apr. 2026, 23:48 UTC

Market Talk

Nikkei May Remain Rangebound Amid Uncertainty Over Iran Conflict -- Market Talk

27 apr. 2026, 23:42 UTC

Market Talk

Australian Consumer Confidence Making a Slow Come Back -- Market Talk

27 apr. 2026, 23:34 UTC

Market Talk

Evenimente importante

Gold Edges Higher as Investors Assess Iran's Proposal to U.S. -- Market Talk

27 apr. 2026, 23:30 UTC

Market Talk

Australia's NDIS Could Lose 'Social Licence' If Not Reined In -- Market Talk

27 apr. 2026, 23:08 UTC

Market Talk

Polymetals's Revenue Outlook 'Extraordinary' for a Small-Cap Stock -- Market Talk

27 apr. 2026, 23:02 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27 apr. 2026, 23:02 UTC

Market Talk

Warsh Will Probably Lean a Bit More Dovish Than Powell -- Market Talk

27 apr. 2026, 22:42 UTC

Market Talk

BOJ Expected to Keep Rates On Hold; Guidance to Skew Hawkish -- Market Talk

27 apr. 2026, 22:10 UTC

Câștiguri

Haier Smart Home: Results Also Weighed by Weak Demand in China-U.S. Markets >600690.SH

27 apr. 2026, 22:09 UTC

Câștiguri

Haier Smart Home: Increase in Tariff Costs, Extreme Weather Conditions Hurt Results >600690.SH

27 apr. 2026, 22:09 UTC

Câștiguri

Haier Smart Home 1Q Net CNY4.65B Vs. Net CNY5.49B >600690.SH

27 apr. 2026, 22:09 UTC

Câștiguri

Haier Smart Home 1Q Rev CNY73.69B Vs. CNY79.12B >600690.SH

27 apr. 2026, 21:56 UTC

Câștiguri

Tsingtao Brewery: Cost Controls Among Factors Supporting Results >0168.HK

27 apr. 2026, 21:55 UTC

Câștiguri

Tsingtao Brewery 1Q Net CNY1.80B Vs. Net CNY1.71B >0168.HK

27 apr. 2026, 21:55 UTC

Câștiguri

Tsingtao Brewery 1Q Rev CNY10.29B Vs. CNY10.45B >0168.HK

27 apr. 2026, 21:44 UTC

Câștiguri

Tianqi Lithium: Higher Demand for Products From EV Sector Also Boosted Financial Performance >002466.SZ

27 apr. 2026, 21:43 UTC

Câștiguri

Tianqi Lithium: Increase in Average Selling Prices of Major Lithium Products Supported Results >002466.SZ

27 apr. 2026, 21:41 UTC

Câștiguri

Tianqi Lithium 1Q Rev CNY5.13B Vs. CNY2.58B >002466.SZ

27 apr. 2026, 21:41 UTC

Câștiguri

Tianqi Lithium 1Q Net CNY1.88B Vs. Net CNY104.27M >002466.SZ

27 apr. 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

27 apr. 2026, 20:50 UTC

Market Talk

Evenimente importante

Basic Materials Roundup: Market Talk

27 apr. 2026, 20:50 UTC

Market Talk

Achiziții, Fuziuni, Preluări

Financial Services Roundup: Market Talk

27 apr. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

27 apr. 2026, 20:39 UTC

Câștiguri

Nucor: Operating Segments Earnings Growth Driven by Trade Policies That Continue to Reduce Flood of Unfairly Traded Imports Into U.S. >NUE

Comparație

Modificare preț

Avita Therapeutics Inc Așteptări

Obiectiv de preț

By TipRanks

41.93% sus

Prognoză pe 12 luni

Medie 6.33 USD 41.93%

Maxim 10 USD

Minim 3.5 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAvita Therapeutics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

4 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 4 analiști care au acordat evaluări ale acțiunilor Avita Therapeutics Inc - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

8.83 / 9.77Suport & Rezistență

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.